These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 2566996)

  • 1. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification.
    Fong CT; Dracopoli NC; White PS; Merrill PT; Griffith RC; Housman DE; Brodeur GM
    Proc Natl Acad Sci U S A; 1989 May; 86(10):3753-7. PubMed ID: 2566996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of genetic rearrangements in human neuroblastomas.
    Brodeur GM
    Clin Chem; 1989 Jul; 35(7 Suppl):B38-42. PubMed ID: 2568197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.
    Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM
    Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification.
    Caron H; van Sluis P; van Hoeve M; de Kraker J; Bras J; Slater R; Mannens M; Voûte PA; Westerveld A; Versteeg R
    Nat Genet; 1993 Jun; 4(2):187-90. PubMed ID: 8102298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelotype of neuroblastoma.
    Takita J; Hayashi Y; Kohno T; Shiseki M; Yamaguchi N; Hanada R; Yamamoto K; Yokota J
    Oncogene; 1995 Nov; 11(9):1829-34. PubMed ID: 7478611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
    Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.
    White PS; Maris JM; Beltinger C; Sulman E; Marshall HN; Fujimori M; Kaufman BA; Biegel JA; Allen C; Hilliard C; Valentine MB; Look AT; Enomoto H; Sakiyama S; Brodeur GM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5520-4. PubMed ID: 7777541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
    Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
    Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of clinical heterogeneity in neuroblastoma.
    Brodeur GM; Nakagawara A
    Am J Pediatr Hematol Oncol; 1992 May; 14(2):111-6. PubMed ID: 1356315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma consensus deletion maps to 1p36.1-2.
    Weith A; Martinsson T; Cziepluch C; Brüderlein S; Amler LC; Berthold F; Schwab M
    Genes Chromosomes Cancer; 1989 Nov; 1(2):159-66. PubMed ID: 2487156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma.
    Suzuki T; Yokota J; Mugishima H; Okabe I; Ookuni M; Sugimura T; Terada M
    Cancer Res; 1989 Mar; 49(5):1095-8. PubMed ID: 2563671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.
    Caron H; Peter M; van Sluis P; Speleman F; de Kraker J; Laureys G; Michon J; Brugières L; Voûte PA; Westerveld A
    Hum Mol Genet; 1995 Apr; 4(4):535-9. PubMed ID: 7633401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma.
    Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M
    Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroblastoma. Effect of genetic factors on prognosis and treatment.
    Brodeur GM; Azar C; Brother M; Hiemstra J; Kaufman B; Marshall H; Moley J; Nakagawara A; Saylors R; Scavarda N
    Cancer; 1992 Sep; 70(6 Suppl):1685-94. PubMed ID: 1325279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma.
    Caron H
    Med Pediatr Oncol; 1995 Apr; 24(4):215-21. PubMed ID: 7700165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
    Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroblastoma--clinical applications of molecular parameters.
    Brodeur GM
    Brain Pathol; 1990 Sep; 1(1):47-54. PubMed ID: 1669693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM; Hiemstra JL; Schneider SS; Kaufman BA; Naumova A; Cheung NK; Cohn SL; Diller L; Sapienza C; Brodeur GM
    Prog Clin Biol Res; 1994; 385():43-9. PubMed ID: 7972236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peculiar allelotype associated with susceptibility to neuroblastoma.
    Perri P; Pession A; Mazzocco K; Strigini P; Iolascon A; Basso G; Tonini GP
    Genes Chromosomes Cancer; 1996 Sep; 17(1):60-3. PubMed ID: 8889508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.